Jon Bates - Apr 1, 2023 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role
Chief Financial Officer
Signature
/s/ John C. Bates
Stock symbol
NUTX
Transactions as of
Apr 1, 2023
Transactions value $
$0
Form type
4
Date filed
5/10/2023, 04:00 PM
Previous filing
Jul 21, 2022
Next filing
Jun 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUTX Common Stock Options Exercise $0 +49.5K $0.00 49.5K Apr 1, 2023 Direct F1
transaction NUTX Common Stock Options Exercise $0 +20K +40.4% $0.00 69.5K Apr 1, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUTX Restricted Stock Unit Award $0 +149K $0.00 149K Apr 1, 2023 Common Stock 149K Direct F1, F2
transaction NUTX Restricted Stock Unit Options Exercise $0 -49.5K -33.33% $0.00 99K Apr 1, 2023 Common Stock 49.5K Direct F1, F2
transaction NUTX Restricted Stock Unit Award $0 +20K $0.00 20K Apr 1, 2023 Common Stock 20K Direct F1, F3
transaction NUTX Restricted Stock Unit Options Exercise $0 -20K -100% $0.00* 0 Apr 1, 2023 Common Stock 20K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.
F2 Pursuant to the Restricted Stock Unit Agreement by and between the issuer and Mr. Bates, dated April 1, 2023, the 148,515 RSUs granted to Mr. Bates will vest in three equal installments, with the initial 1/3 immediately vested on April 1, 2023, and the remaining RSUs vesting 1/3 each on March 1, 2024 and March 1, 2025.
F3 Represents 20,000 RSUs issued and vested on April 1, 2023.